Back
TScan Therapeutics Vs. Doximity Industry Stock Comparison
Sell
30
TCRX
TScan Therapeutics
Last Price:
$1.52
Seasonality Move:
-6.1%
Buy
75
DOCS
Doximity
Last Price:
$61.58
Seasonality Move:
15.61%
Sell
30
TScan Therapeutics (TCRX)
is a Sell
Is TScan Therapeutics a Buy, Sell or Hold?
-
The current TScan Therapeutics [TCRX] share price is $1.51. The Score for TCRX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
TCRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TCRX Stock Price Chart
What is TScan Therapeutics's stock price today?
-
The TScan Therapeutics share price today is $1.51The current trend is relatively stagnant and TCRX is experiencing slight buying pressure.
TCRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 50.19 | Buy |
Chaikin Money Flow: | 71522 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.44 - 1.68) | Sell |
Bollinger Bands (100): | (1.31 - 1.87) | Sell |
DOCS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.29 | Buy |
Relative Strength Index (14 RSI): | 62.06 | Buy |
Chaikin Money Flow: | 1049444 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.58 - 60.18) | Buy |
Bollinger Bands (100): | (52.82 - 67.46) | Buy |
TCRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.5 | Buy |
20-day SMA: | 1.55 | Sell |
50-day SMA: | 1.49 | Buy |
200-day SMA: | 2.86 | Sell |
8-day EMA: | 1.48 | Buy |
20-day EMA: | 1.51 | Buy |
50-day EMA: | 1.54 | Sell |
200-day EMA: | 2.71 | Sell |
DOCS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 60.13 | Buy |
20-day SMA: | 58.55 | Buy |
50-day SMA: | 56.79 | Buy |
200-day SMA: | 55.08 | Buy |
8-day EMA: | 59.88 | Buy |
20-day EMA: | 58.49 | Buy |
50-day EMA: | 57.54 | Buy |
200-day EMA: | 53.26 | Buy |
TScan Therapeutics Earnings Growth & TCRX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.11 per share, and an increase next year of $0.07 per share.
Doximity Earnings Growth & DOCS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.41 per share, and an increase next year of $0.14 per share.
TScan Therapeutics Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Doximity Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |